Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Biotechnology

Healthcare
$18.98 -0.05%

-$0.01 today

Market cap
$912.33M
Beta
0.00
52W Low $15.35High $20.30

Volume 0.37M

Average 0.43M

ODTX Total Assets

Everything the company owns or controls; equal to total liabilities plus equity.

No reported Total Assets figures are available to summarize.

Total Assets history

Currency unavailable · from the balance sheet

No Total Assets data reported for this period type.

Total Assets vs competitors

How ODTX compares with its peers on the latest reported figures

ODTX Competitors
Total Assets for ODTX and competitors
Company Period Latest balance YoY 3-year CAGR
ORKAOruka Therapeutics, Inc.Sep 2026$1.23B USD+141.7%+124.7%
SYRESpyre Therapeutics, Inc.Sep 2026$1.1B USD+117.9%+121.9%
PTGXProtagonist Therapeutics, Inc.Jun 2026$885.54M USD+23.3%+39.3%
ALMSAlumis Inc. Common StockJun 2026$560.62M USD-8.2%+56.2%
ANABAnaptysBio, Inc.Mar 2026$329.68M USD-21.9%-15.8%
ACRSAclaris Therapeutics, Inc.Mar 2026$198.72M USD+0.3%-14.3%
IMUXImmunic, Inc.Mar 2026$189.74M USD+824.9%-42.7%
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025€165.63M EUR——
ODTXOdyssey Therapeutics, Inc.—— ——
Peer median (excluding ODTX) —+23.3%+39.3%

Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Intrinsic Alpha fair value

Locked

Current Price

$18.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.